Retnowati, Endang and Hidayati, Wiyanda and Liana (2010) AKTIVITAS FOSFOLIPASE-A2 SEKRETORIS PLASMA TROMBOSITOPENIA DEMAM BERDARAH DENGUE (Plasma Secretory Phospholipase-A2 Activity in Thrombocytopenic Dengue Haemorrhagic Fever). Indonesian Journal of Clinical Pathology and Medical Laboratory, 17 (1). pp. 12-20. ISSN 0854-4263

	Text (Peerreview) Peerreview3.aktivitas.pdf Restricted to Registered users only Download (905kB) | Request a copy
	Text (Peerreview) karil3.aktivitas.pdf Restricted to Registered users only Download (769kB) | Request a copy

Abstract

Infected macrophages by dengue virus will produce phospholipase-A2 (PLA2) enzyme, that can promote arachidonic acid metabolism that produce inflammatory mediators, causing endhothelial damage and severe plasma leakage. Capillary endothelial damage can cause platelet adhesion and aggregation, so that many platelets will be consumed. The role of sPLA2 (secretory phospholipase-A2), which is a part of PLA2 in dengue and thrombocytopenia up to now has not been widely studied. The objective of the study is to analyze the association between the activity of plasma secretory phospholipase-A2 and the degree of thrombocytopenia in DHF adult patients. the study is carried out by a cross sectional, observational analytical study on 45 hospitalized adult patients suffering dengue hemorrhagic fever in the Tropical Infection Ward, Department of Internal Medicine, Dr. Soetomo Hospital Surabaya, which has been conducted from February–December 2009. The diagnosis of Dengue Haemorrhagic Fever (DHF) was based on the 1997 World Health Organization (WHO) criteria, that minimally had one positive serology marker of dengue. Venous blood was taken from the patient for examining the activity of secretory phospholipase-A2 by correlated enzyme assay method, and platelet count using automated hematology analyzer. The results of the secretory phospholipase-A2 activity and degree of thrombocytopenia were analyzed by Pearson correlation test to determine the correlation between the two variables. In this study so far was found that the secretory phospholipase-A2 activity in DHF patients was 36.9–195.6 unit/mL (mean 97.49 unit/mL, SD 30.06 unit/mL). The mean of secretory phospholipase-A2 activity was increased according to the degree of thrombocytopenia severity. The mean of secretory phospholipase-A2 activities were 91.65 unit/mL, 98.94 unit/mL, and 110.47 unit/mL. The degree of thrombocytopenia was divided into mild, moderate, and severe. Most of the patients showed mild thrombocytopenia. The sPLA2 activity in this study was increased in DHF patients with second day of fever, and then decreased at the third and forth day of fever, and increased in DBD patients suffering fifth day of fever. The statistical analyzes show a non significant correlation between secretory phospholipase- A2 activity and degree of thrombocytopenia (p = 0.579). This result may be caused by several factors which influencing the thrombocytopenia in DHF, such as bone marrow suppression, dengue viral serotype, influence of cytosolic phospholipase-A2 (cPLA2) activity, and other proinflammatory cytokines which in this study could not be controlled. Statistical analyzes show a significant correlation between sPLA2 activity and the day of fever (p = 0.04). Further studies should have to be carried out in order to know the pattern of sPLA2 activity in DHF grade I, II, III, and IV, and to know the influence of other proinflammatory cytokines and viral serotypes in sPLA2 activities.

Actions (login required)

View Item